Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bartron Medical Imaging is a medical technology company specializing in advanced image processing and enhancement for diagnostic applications. The company's core technology, the MED-I (Medical Electronic Device for Imaging) system, utilizes NASA-developed Hierarchical Segmentation (HSEG) algorithms to provide high-resolution, detailed analysis of medical images. This platform assists clinicians in the early detection and diagnosis of various conditions, including breast and prostate cancers, by extracting subtle data from standard imaging modalities like mammography and microscopy. By improving the clarity and segmentation of complex biological images, Bartron aims to enhance diagnostic accuracy and streamline clinical workflows. The MED-I system has received FDA 510(k) clearance for use in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bartron Medical Imaging.